SignalXSignalX

CGEM Cullinan Therapeutics, Inc.

8-K Current Report
Filed: March 10, 2026
Health Care
Biological Products, (No Diagnostic Substances)
Cullinan Therapeutics, Inc. Overview

Cullinan Therapeutics, Inc. (CGEM) 8-K current report filed with SEC EDGAR on March 10, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Full-year 2025 financial results announced March 10, 2026
  • • Complete figures in Exhibit 99.1 press release — refer there for revenue, cash, and expense details

Get deeper insights on Cullinan Therapeutics, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.